Salmon-calcitonin nasal spray regulatory update

FDA granted tentative approval to an ANDA from MDRNA for generic calcitonin-salmon nasal spray to treat osteoporosis. Final approval is expected in June 2009 after the expiration of a 180-day exclusi...